Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · IEX Real-Time Price · USD
7.44
+0.11 (1.50%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $793.98 million as of April 26, 2024. Its market cap has increased by 163.17% in one year.
Market Cap
793.98M
Enterprise Value
495.16M
1-Year Change
163.17%
Ranking
Category
Stock Price
$7.44
Market Cap Chart
Since September 3, 2020, Tango Therapeutics's market cap has increased from $164.40M to $793.98M, an increase of 382.96%. That is a compound annual growth rate of 54.01%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 26, 2024 | 794.00M | 1.51% |
Apr 25, 2024 | 782.20M | -5.54% |
Apr 24, 2024 | 828.10M | -0.13% |
Apr 23, 2024 | 829.20M | 6.29% |
Apr 22, 2024 | 780.10M | - |
Apr 19, 2024 | 780.10M | -0.81% |
Apr 18, 2024 | 786.50M | -1.21% |
Apr 17, 2024 | 796.10M | 1.49% |
Apr 16, 2024 | 784.40M | 0.41% |
Apr 15, 2024 | 781.20M | -0.53% |
Apr 12, 2024 | 785.40M | -3.04% |
Apr 11, 2024 | 810.00M | 1.61% |
Apr 10, 2024 | 797.20M | -2.98% |
Apr 9, 2024 | 821.70M | 3.63% |
Apr 8, 2024 | 792.90M | 0.67% |
Apr 5, 2024 | 787.60M | -3.40% |
Apr 4, 2024 | 815.30M | -0.52% |
Apr 3, 2024 | 819.60M | 1.59% |
Apr 2, 2024 | 806.80M | -1.04% |
Apr 1, 2024 | 815.30M | -3.78% |
Mar 28, 2024 | 847.30M | 3.12% |
Mar 27, 2024 | 821.70M | 2.52% |
Mar 26, 2024 | 801.50M | -1.57% |
Mar 25, 2024 | 814.30M | -1.29% |
Mar 22, 2024 | 824.90M | -5.96% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Definitive Healthcare | 853.97M |
Sage Therapeutics | 841.49M |
Tyra Biosciences | 840.38M |
Zentalis Pharmaceuticals | 835.20M |
Relay Therapeutics | 832.99M |
Healthcare Services Group | 825.60M |
EyePoint Pharmaceuticals | 820.71M |
Enliven Therapeutics | 818.63M |